General presentation of Vertex Pharmaceuticals
We now invite you to discover a little more information about Vertex Pharmaceuticals and its activities. Indeed, it is essential that you understand how this group generates its revenues before speculating on its share price.
The Vertex Pharmaceuticals group is a US company specialising in the research, development and marketing of micro-molecular drugs, particularly for the treatment of certain cancers, viral diseases, inflammatory diseases and autoimmune diseases.
In order to better understand Vertex's activities, they can be divided into different divisions according to the share of turnover they generate :
- The sale of products represents the major part of this group's revenue with 99.9% of turnover.
- This is followed by royalties and income from partnership, research and development agreements for 0.1% of turnover.
The geographical distribution of this group's revenues is also interesting to know and it should be noted that Vertex achieves 73.6% of its turnover in the United States, 21.3% in Europe and 5.1% in the rest of the world.
72% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on Plus500